-
February 01, 2013
Perrigo Company's (PRGO) third quarter fiscal 2012 (ended March 31, 2012) adjusted earnings of $1.41 handsomely beat ...
-
February 01, 2013
Alkermes plc (ALKS) reported earnings of 14 cents per share in the third quarter of fiscal 2013 (ended December 31, ...
-
January 30, 2013
Vertex Pharmaceuticals Inc. (VRTX) posted a loss of 9 cents per share (including stock-based compensation expense) ...
-
January 30, 2013
Better-than-expected quarterly results once again guided the S&P 500 and the Dow Jones into the green on Tuesday. ...
-
January 30, 2013
Procter & Gamble is delivering on its promises for better performances.
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 28, 2013
Poor reporting and weak margins undermine the potential of Abbott.
-
January 23, 2013
Better-than-expected earnings from major companies lifted benchmarks into positive territory on Tuesday ahead of ...
-
January 22, 2013
International health care product major, Covidien plc. (COV) recently revealed approval from the Food and Drug ...
-
January 22, 2013
Johnson & Johnson's (JNJ) fourth quarter 2012 earnings (excluding special items) of $1.19 per share were a couple of ...
-
January 22, 2013
Stryker's acquisition of Trauson is the right deal at the right time.
-
January 22, 2013
Stocks will likely take a breather today given the mixed earnings picture emerging from a busy reporting day. The ...
-
January 22, 2013
Tuesday, January 22, 2013 Stocks will likely take a breather today given the mixed earnings picture emerging from ...
-
January 21, 2013
Johnson & Johnson (JNJ) is slated to report its second quarter 2012 earnings on July 17, 2012 before the opening ...
-
January 21, 2013
Allergan Inc. (AGN) recently received a major boost with the US Food and Drug Administration (FDA) approving Botox ...
-
January 17, 2013
AstraZeneca (AZN) recently announced that the company has created seven positions in the senior executive team. At ...
-
January 17, 2013
Pfizer Inc. (PFE) recently announced that it has launched its attention deficit hyperactivity disorder (ADHD) ...
-
January 17, 2013
Eli Lilly and Company (LLY) recently announced the approval of its radioactive diagnostic agent, Amyvid (florbetapir ...
-
January 16, 2013
Johnson & Johnson's (JNJ) Janssen-Cilag International NV recently announced that the European Commission (EC) has ...
